HHC
AMED

Hutchin Hill Capital’s Amedisys AMED Stock Holding History

Hutchin Hill Capital’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-48,300
Closed -$831K – 516
2013
Q3 		$831K Buy
+48,300
New +$716K 0.08% 202

Other funds holding AMED

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hutchin Hill Capital's AMED Position: Q4 2013 in Review

Hutchin Hill Capital sold out of Amedisys (AMED) in Q4 2013, closing a stake of 48,300 shares — an estimated $831K sold.

Hutchin Hill Capital first reported a position in AMED in Q3 2013 and held it in 1 quarter. The position peaked at $831K in Q3 2013. 124 funds tracked by Wall St. Rank hold AMED as of Q4 2013.

  • Hutchin Hill Capital reported no remaining Amedisys position as of Q4 2013 after selling out during the quarter.
  • Hutchin Hill Capital sold 48,300 Amedisys shares in Q4 2013, an estimated $831K.
  • Hutchin Hill Capital first reported a position in Amedisys in Q3 2013 and held it in 1 quarter.
  • Hutchin Hill Capital's Amedisys position peaked at $831K in Q3 2013.
  • 124 funds tracked by Wall St. Rank held Amedisys as of Q4 2013.

Based on Hutchin Hill Capital's 13F filing for Q4 2013, filed 14 Feb 2014.